GPs keen on Ivermectin trials told to seek research outfit’s advice

[superadmin]

PETALING JAYA: The government has told private doctors to seek the advice of Clinical Research Malaysia (CRM) if they are interested in conducting clinical trials on Ivermectin, a controversial drug touted as a cure for Covid-19.

CRM, which is a one-stop centre to facilitate such research, is a company established by the health ministry.

National Pharmaceutical Regulatory Agency (NPRA) director Dr Roshayati Mohamad Sani said CRM would help general practitioners (GPs) determine the feasibility of clinical trials.

For regulatory requirements, they must refer to the Malaysian Guidelines for the Application of Clinical Trial Import Licence (CTIL) and Clinical Trial Exemption (CTX), she said.

The guidelines can be downloaded from the NPRA website.


- More -